These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32556154)

  • 1. Does hypoperfusion outperform blood pressure as a better predictor in the risk stratification of acute heart failure?
    Zhou Y; Liu F; Nie J
    Eur Heart J; 2020 Jul; 41(25):2411. PubMed ID: 32556154
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous vasodilators in acute heart failure patients with low basic blood pressure: may the benefit come from targeting perfusion rather than pressure?
    Bocchino PP; Angelini F; Frea S
    Eur Heart J; 2020 Jul; 41(25):2409-2410. PubMed ID: 32556107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP; Elsner D; Riegger GA
    Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to: Does hypoperfusion outperform blood pressure as a better predictor in the risk stratification of acute heart failure?
    Eur Heart J; 2021 Jan; 42(4):319. PubMed ID: 33521825
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical assessment of hypoperfusion in acute heart failure – evergreen or antique?
    Frea S; Pidello S; Canavosio FG; Bovolo V; Botta M; Bergerone S; Gaita F
    Circ J; 2015; 79(2):398-405. PubMed ID: 25744753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CHARM of a paradox.
    O'Rourke MF
    J Am Coll Cardiol; 2010 Jan; 55(3):257. PubMed ID: 20117408
    [No Abstract]   [Full Text] [Related]  

  • 7. Agents with vasodilator properties in acute heart failure: how to design successful trials.
    Mebazaa A; Longrois D; Metra M; Mueller C; Richards AM; Roessig L; Seronde MF; Sato N; Stockbridge NL; Gattis Stough W; Alonso A; Cody RJ; Cook Bruns N; Gheorghiade M; Holzmeister J; Laribi S; Zannad F
    Eur J Heart Fail; 2015 Jul; 17(7):652-64. PubMed ID: 26040488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Pressure Reduction in Hypertensive Acute Heart Failure.
    Harrison N; Pang P; Collins S; Levy P
    Curr Hypertens Rep; 2021 Feb; 23(2):11. PubMed ID: 33611627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator Therapy in Acute Heart Failure.
    Curfman G
    JAMA; 2019 Dec; 322(23):2288-2289. PubMed ID: 31846001
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital treatment of congestive heart failure. Management according to hemodynamic profile.
    Forrester JS; Waters DD
    Am J Med; 1978 Jul; 65(1):173-80. PubMed ID: 685990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator treatment for acute and chronic heart failure.
    Chatterjee K; Parmley WW
    Br Heart J; 1977 Jul; 39(7):706-20. PubMed ID: 884021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator treatment for acute and chronic heart failure.
    Warren SE; Dennish G
    Br Heart J; 1978 Sep; 40(9):1059-60. PubMed ID: 708533
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of inhaled nitric oxide in heart failure.
    Semigran MJ; Cockrill BA; Kacmarek R; Thompson BT; Zapol WM; Dec GW; Fifer MA
    J Am Coll Cardiol; 1994 Oct; 24(4):982-8. PubMed ID: 7930234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute heart failure: acute cardiogenic pulmonary edema and cardiogenic shock].
    Sánchez Marteles M; Urrutia A
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():14-9. PubMed ID: 24930078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
    Meredith PA; Ostergren J; Anand I; Puu M; Solomon SD; Michelson EL; Olofsson B; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; McMurray JJ
    J Am Coll Cardiol; 2008 Dec; 52(24):2000-7. PubMed ID: 19055992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seating-induced postural hypotension is common in older patients with decompensated heart failure and may be prevented by lower limb compression bandaging.
    Gorelik O; Almoznino-Sarafian D; Litvinov V; Alon I; Shteinshnaider M; Dotan E; Modai D; Cohen N
    Gerontology; 2009; 55(2):138-44. PubMed ID: 18583904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vasodilator therapy in heart failure.
    Chatterjee K; Parmley WW
    Prog Cardiovasc Dis; 1977; 19(4):301-25. PubMed ID: 401541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study.
    Nomura F; Kurobe N; Mori Y; Hikita A; Kawai M; Suwa M; Okutani Y
    Circ J; 2008 Nov; 72(11):1777-86. PubMed ID: 18832779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.